GGrantIndex
← Search

Flow Cytometry Core

$199,418P30FY2023CANIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

PROJECT SUMMARY – Flow Cytometry and Immune Monitoring Shared Resource The mission of the USC Norris Comprehensive Cancer Center (NCCC) Flow Cytometry and Immune Monitoring Shared Resource (FCIM) is to provide advanced multi-parameter flow cytometry, cell sorting capabilities, and immune monitoring services for advancing basic, translational, and clinical research with options for full-service technical support for cancer clinical trial immune-monitoring correlative studies. NCCC Administration oversees FCIM with Martin Kast PhD (continuing in the role) and Rong Lu PhD (new in the role in 2015) as the faculty Co- Directors. Kast and Lu have extensive and complementary scientific expertise; they meet monthly to provide executive oversight for core services and to promote user access and satisfaction. In response to annual NCCC surveys of Shared Resources (SR) and feedback from the NCCC External Advisory Board, FCIM significantly enhanced services and new equipment during the current grant cycle, including: 1) expanded sorting and high throughput analysis capabilities with 3 new instruments offering more available colors, 2) increased post-sort viability, 3) added services for mass cytometry (CyTOF)-assisted projects; and 4) lowered costs due to improved efficiencies. In the next grant cycle, based on user feedback, FCIM will expand its services to include T cell receptor (TCR) clonality determination and other single cell omics using a newly acquired Illumina MiSeq System in the Molecular Genomics SR and spatial immune profiling with the recently acquired Vector Polaris system in the Translational Pathology SR. During the current grant period (2015-2020), 70 NCCC members representing all five programs utilized FCIM, resulting in 53 publications and $15.9M in direct cost grant funding as a direct result of usage. The anticipated annual budget of FCIM in the first year of the next grant cycle is $632,453, yet the CCSG request is $143,215. Accordingly, FCIM leverages extensive institutional and recharge support and seeks only 23% from CCSG funds.

View original record on NIH RePORTER →